05.11.2013 00:51:25
|
Keryx Biopharma Q3 Loss Widens
(RTTNews) - Keryx Biopharmaceuticals, Inc.(KERX) posted third-quarter net loss of $15.7 million or $0.19 per share, wider than $5.5 million or $0.08 per share in the comparable quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.11 per share. Analysts' estimates typically exclude special items.
The company did not generate any revenues for both the quarters.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Keryx Biopharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |